Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8310490 | Clinica Chimica Acta | 2016 | 8 Pages |
Abstract
The fibrosis biomarker galectin-3, but not sST2, taken immediately after MI, predicts LVEF and infarct size after 4Â months. We hypothesize that galectin-3 may play a role in the pathophysiology of cardiac remodeling after acute MI.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
A. Rogier van der Velde, Chris P.H. Lexis, Wouter C. Meijers, Iwan C. van der Horst, Erik Lipsic, Martin M. Dokter, Dirk J. van Veldhuisen, Pim van der Harst, Rudolf A. de Boer,